As the U.S. exit landscape continues to evolve, alternative approaches—such as SPACs—are making U.S. IPOs accessible to a wider array of European companies. SPAC business combinations have recently offered private companies a potentially efficient way to raise funding at attractive valuations. However, while initially appealing, related factors such as outcome, opportunity, and underlying risks require careful consideration, especially as this red-hot industry faces new challenges ahead.
Lori Doyle
ldoyle@wsgr.comMegan represents technology and life sciences clients in corporate transactional matters.
Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.
Craig represents companies, venture capital firms, and investment banks in private placements and public offerings. He also has M&A, technology licensing, and domestic and international joint venture experience.